Clinical value of interferon‑γ release assay in the diagnosis of active tuberculosis

  • Ai L
  • Feng P
  • Chen D
  • et al.
N/ACitations
Citations of this article
27Readers
Mendeley users who have this article in their library.

Abstract

Sensitivity and specificity of the interferon-gamma release test for active tuberculosis screening were evaluated. Due to the high-test cost of imported IGRAs, QFT-GIT and T-SPOT.TB, we applied a cheaper domestic TB-IGRA which was approved in China recently. We recruited 740 patients and performed tuberculosis interferon release test (IGRAs), detection of Mycobacterium tuberculosis IgG antibody (TB-IgG) and tuberculin skin test (TST). The sensitivity of the three methods are 90.8, 40.0 and 75.45%, with specificity of 76.62, 74.47 and 72.27%. The area under the ROC curve according to the value of T-N detected by IGRAs was 0.878 (95% CI, 0.839-0.917), with the area under the curve for the diagnosis of active pulmonary tuberculosis and extrapulmonary tuberculosis being 0.839 and 0.841 respectively. The interferon-gamma release test seems to be superior to TST and TB-IgG as a screening tool for the detection of active tuberculosis in China.Copyright © 2019, Spandidos Publications. All rights reserved.

Cite

CITATION STYLE

APA

Ai, L., Feng, P., Chen, D., Chen, S., & Xu, H. (2019). Clinical value of interferon‑γ release assay in the diagnosis of active tuberculosis. Experimental and Therapeutic Medicine. https://doi.org/10.3892/etm.2019.7696

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free